Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Cancer Research|November 17, 2005
Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesisHaritha K D L Reddy, Richard V Mettus, Sushil G Rane, et al.Prostate Cancer and Prostatic Diseases|September 3, 2020
Immortalization of human primary prostate epithelial cells via CRISPR inactivation of the CDKN2A locus and expression of telomeraseZiran Zhao, Holly Fowle, Henkel Valentine, et al.Cell Cycle (Georgetown, Tex.)|October 7, 2004
A dynamic equilibrium between CDKs and PP2A modulates phosphorylation of pRB, p107 and p130Judit Garriga, Arun L Jayaraman, Ana Limón, et al.Molecular and Cellular Biology|June 19, 2013
Activation of p107 by fibroblast growth factor, which is essential for chondrocyte cell cycle exit, is mediated by the protein phosphatase 2A/B55α holoenzymeAlison Kurimchak, Dale S Haines, Judit Garriga, et al.Blood|September 28, 2002
Activation of the Jak3 pathway is associated with granulocytic differentiation of myeloid precursor cellsSushil G Rane, James K Mangan, Arshad Amanullah, et al.Research Square|May 20, 2024
Derivation of human primary prostate epithelial cell lines by differentially targeting the <i>CDKN2A</i> locus along with expression of hTERTJason S Wasserman, Holly Fowle, Rumesa Hashmi, et al.Scientific Reports|September 2, 2024
Derivation of human primary prostate epithelial cell lines by differentially targeting the CDKN2A locus along with expression of hTERTJason S Wasserman, Holly Fowle, Rumesa Hashmi, et al.Elife|October 18, 2021
PP2A/B55α substrate recruitment as defined by the retinoblastoma-related protein p107Holly Fowle, Ziran Zhao, Qifang Xu, et al.Oncogenesis|December 12, 2019
PPP2R2A prostate cancer haploinsufficiency is associated with worse prognosis and a high vulnerability to B55α/PP2A reconstitution that triggers centrosome destabilizationZiran Zhao, Alison Kurimchak, Anna S Nikonova, et al.Biorxiv : the Preprint Server for Biology|March 22, 2023
FAM122A ensures cell cycle interphase progression and checkpoint control as a SLiM-dependent substrate-competitive inhibitor to the B55⍺/PP2A phosphataseJason S Wasserman, Bulat Faezov, Kishan R Patel, et al.Pageof 4